Chemical company Lanxess AG, spun off by Bayer in 2005, surprised investors in September with the $2.0 billion acquisition excluding debt of Chemtura Corp. "German Companies on a Tear in U.S.," at 10.30 GMT, said the deal was worth $2.7 billion.

(END) Dow Jones Newswires

January 19, 2017 12:19 ET (17:19 GMT)